DKA Capital logo

DKA Capital

Europe, Hovedstaden, Denmark, Copenhagen

Description

DKA Capital (formerly Dansk Kapitalanlæg) is a well-established Danish PE fund investing in and developing knowledge-intensive growth

Investor Profile

DKA Capital has made 11 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (36%)
  • Debt Financing (18%)
  • Series A (18%)
  • Series Unknown (18%)
  • Series D (9%)

Country Focus

  • United States (36%)
  • Denmark (36%)
  • Germany (18%)
  • Sweden (9%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Biopharma
  • Neuroscience
  • E-learning
  • Education
  • Cleantech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DKA Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Vaekstfonden
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
TK
North America, New York, United States, New York
Co-Investments: 1
Pacific Rim Ventures
North America, California, United States, San Francisco
Co-Investments: 1
LD Pensions
Europe, Nordjylland, Denmark, Aalborg
Co-Investments: 4
BankInvest
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 2
Techno Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Alafi Capital
North America, California, United States, San Francisco
Co-Investments: 1
HH
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by DKA Capital?

CanopyLAB

Copenhagen, Hovedstaden, Denmark

The Future of Learning. Delivered Today

E-LearningEducation
Debt FinancingJan 26, 2021
Amount Raised: $1,500,000
Secunia

Copenhagen, Hovedstaden, Denmark

Secunia is an IT security solutions provider allowing businesses and private individuals globally manage and control vulnerability threats.

Cyber SecuritySecurity
Series UnknownOct 1, 2010
Hymite

Allerød, Hovedstaden, Denmark

Hymite offers wafer-scale silicon packaging technology for use in electronics applications.

CleanTechConsumer ElectronicsElectronics
Series BJan 11, 2007
Amount Raised: $11,500,000
NsGene

Ballerup, Hovedstaden, Denmark

NsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.

BiopharmaBiotechnologyNeuroscience
Series UnknownMay 2, 2005
Amount Raised: $5,140,000
Direct Conversion

Danderyd, Stockholms Lan, Sweden

Direct Conversion is a designer and manufacturer of X-ray imaging components.

Series BJul 1, 2002
Amount Raised: $20,963,075
Develogen AG

Göttingen, Niedersachsen, Germany

A biology-driven drug discovery company developing novel therapies for diabetes and obesity

BiotechnologyHealth CareMedicalTherapeutics
Series BApr 18, 2001
Amount Raised: $35,302,819
Acadia Pharmaceuticals Inc.

San Diego, California, United States

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Debt FinancingJun 20, 2000
Amount Raised: $22,000,000
HepaVec AG

Berlin, Berlin, Germany

HepaVec AG is a privately held biotechnology company.

BiotechnologyMedicalTherapeutics
Series AMay 8, 2000
Amount Raised: $4,400,000
Acadia Pharmaceuticals Inc.

San Diego, California, United States

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series DAug 31, 1998
Amount Raised: $10,700,000
Acadia Pharmaceuticals Inc.

San Diego, California, United States

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series BAug 13, 1997
Amount Raised: $3,000,000